To determine whether TRN2 misexpression is sufficient to mimic the crc mutant phenotype, we expressed TRN2 under the control of the CRC promoter (pCRC::TRN2) (Fig. 6a–d). The gene discussed is TNPO2; the disease is colorectal carcinoma.